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Positron emission tomography (PET) recently has
proved useful in the staging of lung carcinoma, specifi-
cally in the determination of the presence of nodal disease
and distant metastases. In several studies up to 18% of
patients considered to be resectable have more advanced
disease demonstrated by PET imaging.
Regarding nodal staging, the sensitivity of PET
has been reported in the range of 76–100% and
specificity in the range of 82–100%. Nearly all studies
have demonstrated the superiority of FDG PET over
CT scanning in the evaluation of nodal disease. A
recent study by Peterman et al of 102 patients with
nonsmall cell lung cancer demonstrated a sensitivity
for PET in the detection of nodal disease of 91%
with a specificity of 86%. Despite the superiority of
PET over CT scanning, the resolution of PET makes
determination of the extent of tumor and involvement
of individual lymph node groups difficult although this
should improve with the advent of combined CT PET
scanners.
In addition, PET seems to improve the noninvasive
detection of extrathoracic disease. Whole body PET
can stage intrathoracic and extrathoracic disease in a
single examination and has an overall greater accuracy
than conventional imaging. Whole body PET can detect
unsuspected extrathoracic metastases in up to 10% of
patients when CT scanning fails to detect them, and also
alters management in up to 40% of cases.
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